Log in
Enquire now
Vikas Sinha

Vikas Sinha

Allovir’s President and Chief Financial Officer

OverviewStructured DataIssuesContributors

All edits by  Андрей Вишняков 

Edits on 23 Feb, 2022
Андрей Вишняков profile picture
Андрей Вишняков
edited on 23 Feb, 2022
Edits made to:
Infobox (+1 properties)
Description (+47 characters)
Article (+899 characters)
Topic thumbnail

Vikas Sinha

Allovir’s President and Chief Financial Officer

Article

Vikas Sinha, our President and Chief Financial Officer, brings over 25 years of experience in executive finance roles within the biopharmaceutical industry. He served as the Chief Financial Officer of Alexion Pharmaceuticals for more than 11 years, where he oversaw the global expansion of the company across 50 countries and revenue growth to more than $3 billion. Prior to joining Alexion, Vikas held various positions with Bayer AG across the world, including CFO, Bayer Pharma, North America and CFO, Bayer Yakuhin, Japan. He also serves as Chief Financial Officer of ElevateBio and an Independent Director and Audit Committee Chair at Verona.

...

Vikas received his M.B.A. from the Asian Institute of Management, Manila, Philippines. He is a qualified Chartered Accountant and associate member of the Institute of Chartered Accountants of India and a Certified Public Accountant in the UnitedStates.

Infobox
LinkedIn
https://www.linkedin.com/in/vikas-sinha-71521a132/

Find more people like Vikas Sinha

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.